Buy One Get One free -Llimited Time Offer X
Gate (Ajanta) is a prescription drug, available for use as Drops. It is primarily used for the treatment of Conjunctivitis. Secondary and off-label uses of Gate (Ajanta) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Gate (Ajanta). The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Gate (Ajanta) include Nausea or vomiting, Diarrhoea, Dizziness. Apart from the aforementioned side effects, Gate (Ajanta) can also lead to other problems, which have been listed below. Usually, these side effects of Gate (Ajanta) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Gate (Ajanta)'s effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Gate (Ajanta)'s effects on the liver, heart and kidney, if any, have been listed below.
Gate (Ajanta) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Gate (Ajanta) in conditions like Myasthenia Gravis (MG), Brain and Nervous System, Tendon Injury (Tendinopathy). The section on Gate (Ajanta) contraindications lists all such conditions.
Besides this, Gate (Ajanta) may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Gate (Ajanta) is safe while driving, and is is addictive in nature.
Gate (Ajanta) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Gate (Ajanta) is used -
Moderate
Mild
Common
Is the use of Gate (Ajanta) safe for pregnant women?
Gate can have harmful effects in pregnant women. If you experience any discomfort after using Gate, then discontinue the use and take your doctor's advice.
Is the use of Gate (Ajanta) safe during breastfeeding?
Gate may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Gate (Ajanta) on the Kidneys?
Using Gate does not have any harmful effects on kidneys.
What is the effect of Gate (Ajanta) on the Liver?
Gate is not harmful for the liver.
What is the effect of Gate (Ajanta) on the Heart?
You can take Gate without any fear of damage to the heart.
Gate (Ajanta) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gate (Ajanta) unless your doctor advises you to do so -
Is this Gate (Ajanta) habit forming or addictive?
Gate (Ajanta) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Gate (Ajanta) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
No, Gate (Ajanta) is not completely safe.
Is it able to treat mental disorders?
There is no benefit of taking Gate (Ajanta) for mental disorders.
Interaction between Food and Gate (Ajanta)
Some foods when eaten with Gate (Ajanta) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Gate (Ajanta)
It is difficult to say anything about the effect of Gate (Ajanta) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZymaxidY™ (gatifloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399